Xiupeng Chen

6PUBLICATIONS

28CO-AUTHORS

Gene and molecular therapyNanoelectronicsMedical devicesSurface properties of condensed matter

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 25, 2026

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model.

|May 23, 2026

Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice.

|Jan 19, 2026

An engineered UGA suppressor tRNA gene for disease-agnostic AAV delivery.

Mengyao Xu, Hao Liu, Jiaming Wang

|May 16, 2025

High-purity AAV vector production utilizing recombination-dependent minicircle formation and genetic coupling.

Hao Liu, Nan Liu, Chen Zhou

|Feb 27, 2024

Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor.

Qing Xie, Xiupeng Chen, Hong Ma

|Jan 30, 2023

Endogenous ceramide phosphoethanolamine modulates circadian rhythm via neural-glial coupling in <i>Drosophila</i>.

Xiupeng Chen, Jie Li, Zhongbao Gao

Pageof 1

Frequent Collaborators

Phillip Wl Tai

Jun Xie

Guangping Gao

Nan Liu

Dan Wang

Thomas L Gallagher

Hao Liu

Zuoshang Xu

Mayank Kapadia

Yingchun Wang

Frequent Collaborators

Phillip Wl Tai

Jun Xie

Guangping Gao

Nan Liu